From waste to UV armor: development and optimization of cost-effective biocompatible graphene quantum dots for melanoma prevention

Active Project Grant Awarded Last action

Award ID
HT9425261E454
Recipient
Awarding agency
Obligated
$1,118,013

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 0% complete
Place of performance
Cleveland, OH 44195, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded The Cleveland Clinic Foundation $1,118,013 on November 1, 2026, to develop and optimize cost-effective biocompatible graphene quantum dots for melanoma prevention under the Military Medical Research and Development program (CFDA 12.420). Work is performed in Cleveland, Ohio, with a period of performance through October 31, 2029. The project transitions graphene quantum dot technology from waste feedstock into ultraviolet-protective biocompatible compounds intended for melanoma prevention applications. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative research and investigation of medical solutions for battlefield conditions, with awards typically ranging from $100,000 to $20 million across award periods averaging three to four years.

Quick answers

Who received award HT9425261E454?

HT9425261E454 was awarded to The Cleveland Clinic Foundation by Defense Health Agency (Department of Defense) on November 1, 2026.

How much is award HT9425261E454 worth?

$1,118,013 has been obligated on HT9425261E454.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login